Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Roma EH"'
Autor:
Muryam Abdul Razzaq, Waqas Younis, Muhammad Nasir Hayat Malik, Tariq G. Alsahli, null Alamgeer, Shah Jahan, Roma Ehsan, Arquimedes Gasparotto Junior, Asifa Bashir
Publikováno v:
Cardiovascular Therapeutics, Vol 2023 (2023)
The current study was designed to determine pulegone’s antihypertensive and vasoprotective activity in L-NAME-induced hypertensive rats. Firstly, the hypotensive dose-response relationship of pulegone was evaluated in normotensive anesthetized rats
Externí odkaz:
https://doaj.org/article/7f5eb8d1a11046c1893d00bb654f4be0
Autor:
de Lima MR; Laboratory of Immunology and Immunogenetic in Infectious Diseases, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, RJ, Brazil., Leandro ACCS; Laboratory of Immunology and Immunogenetic in Infectious Diseases, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, RJ, Brazil.; Division of Human Genetics, South Texas Diabetes and Obesity Institute, The University of Texas Rio Grande Valley, Brownsville, TX 78520, USA., de Souza AL; Laboratory of Immunology and Immunogenetic in Infectious Diseases, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, RJ, Brazil., Barradas MM; Laboratory of Immunology and Immunogenetic in Infectious Diseases, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, RJ, Brazil., Roma EH; Laboratory of Immunology and Immunogenetic in Infectious Diseases, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, RJ, Brazil., Fernandes ATG; Laboratory of Immunology and Immunogenetic in Infectious Diseases, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, RJ, Brazil., Galdino-Silva G; Laboratory of Immunology and Immunogenetic in Infectious Diseases, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, RJ, Brazil., Carvalho JKMR; Laboratory of Immunology and Immunogenetic in Infectious Diseases, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, RJ, Brazil., Marchevsky RS; Laboratory of Neurovirulence, Instituto de Biotecnologia em Imunobiológicos, Biomanguinhos, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, RJ, Brazil., Coelho JMCO; Laboratory of Pathology, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, RJ, Brazil., Gonçalves EDC; Farmacore Biotecnologia Ltda, Ribeirão Preto 14056-680, SP, Brazil., VandeBerg JL; Division of Human Genetics, South Texas Diabetes and Obesity Institute, The University of Texas Rio Grande Valley, Brownsville, TX 78520, USA., Silva CL; Farmacore Biotecnologia Ltda, Ribeirão Preto 14056-680, SP, Brazil.; Laboratory for Research and Development of Immunobiologicals, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14049-900, SP, Brazil., Bonecini-Almeida MDG; Laboratory of Immunology and Immunogenetic in Infectious Diseases, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, RJ, Brazil.
Publikováno v:
Vaccines [Vaccines (Basel)] 2023 Dec 18; Vol. 11 (12). Date of Electronic Publication: 2023 Dec 18.
Autor:
Schor D; Laboratório de Imunologia e Imunogenética em Doenças Infecciosas, Instituto Nacional de Infectologia Evandro Chagas-INI/FIOCRUZ, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21040-900, Brazil., Porto LC; Laboratório de Histocompatibilidade e Criopreservação, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ, 20950-000, Brazil., Roma EH; Laboratório de Imunologia e Imunogenética em Doenças Infecciosas, Instituto Nacional de Infectologia Evandro Chagas-INI/FIOCRUZ, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21040-900, Brazil. eric.roma@ini.fiocruz.br., Castro-Alves J; Plataforma de Pesquisa Clínica, Instituto Nacional de Infectologia Evandro Chagas-INI/FIOCRUZ, Rio de Janeiro, RJ, 21040-900, Brazil., Villela AP; Laboratório de Histocompatibilidade e Criopreservação, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ, 20950-000, Brazil., Araújo AQC; Laboratório de Pesquisa Clínica em Neuroinfecções, Instituto Nacional de Infectologia Evandro Chagas-INI/FIOCRUZ, Rio de Janeiro, RJ, 21040-900, Brazil., Glória Bonecini-Almeida M; Laboratório de Imunologia e Imunogenética em Doenças Infecciosas, Instituto Nacional de Infectologia Evandro Chagas-INI/FIOCRUZ, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21040-900, Brazil.
Publikováno v:
Scientific reports [Sci Rep] 2023 May 11; Vol. 13 (1), pp. 7659. Date of Electronic Publication: 2023 May 11.
Autor:
Costa MFS; Instituto de Biologia, Departamento de Imunobiologia, Universidade Federal Fluminense, Niteroi, Brazil.; Center for Technological Development in Health, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France., Pereira-Dutra F; Immunopharmacology Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Deboosere N; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France., Jouny S; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France., Song OR; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France., Iack G; Instituto de Biologia, Departamento de Imunobiologia, Universidade Federal Fluminense, Niteroi, Brazil.; Immunopharmacology Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Souza AL; Fundação Oswaldo Cruz, Laboratory of Immunology and Immunogenetics in Infectious Diseases at Evandro Chagas National Institute of Infectious Diseases, Rio de Janeiro, Brazil., Roma EH; Fundação Oswaldo Cruz, Laboratory of Immunology and Immunogenetics in Infectious Diseases at Evandro Chagas National Institute of Infectious Diseases, Rio de Janeiro, Brazil., Delorme V; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France., Bozza PT; Immunopharmacology Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Brodin P; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France.
Publikováno v:
Molecular microbiology [Mol Microbiol] 2023 Feb; Vol. 119 (2), pp. 224-236. Date of Electronic Publication: 2023 Jan 16.
Autor:
Fernandes ATG; Laboratory of Immunology and Immunogenetics in Infectious Diseases at Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Avenida Brasil 4365, Rio de Janeiro, RJ, 21040-900, Brazil. ana.fernandes@ini.fiocruz.br., Carvalho MOO; Laboratory of Immunology and Immunogenetics in Infectious Diseases at Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Avenida Brasil 4365, Rio de Janeiro, RJ, 21040-900, Brazil., Avvad-Portari E; Department of Pathologic Anatomy at Fernandes Figueira Woman, Child and Adolescent's Health National Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Rocha NP; Laboratory of Immunology and Immunogenetics in Infectious Diseases at Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Avenida Brasil 4365, Rio de Janeiro, RJ, 21040-900, Brazil., Russomano F; Department of Gynecology at Fernandes Figueira Woman, Child and Adolescent's Health National Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Roma EH; Laboratory of Immunology and Immunogenetics in Infectious Diseases at Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Avenida Brasil 4365, Rio de Janeiro, RJ, 21040-900, Brazil., Bonecini-Almeida MDG; Laboratory of Immunology and Immunogenetics in Infectious Diseases at Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Avenida Brasil 4365, Rio de Janeiro, RJ, 21040-900, Brazil.
Publikováno v:
Scientific reports [Sci Rep] 2021 Apr 22; Vol. 11 (1), pp. 8782. Date of Electronic Publication: 2021 Apr 22.
Autor:
Gonçalves JL; Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Serviço de Nutrição, Rio de Janeiro, RJ, Brasil., Silva MCA; Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Serviço de Nutrição, Rio de Janeiro, RJ, Brasil.; Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Imunologia e Imunogenética em Doenças Infecciosas, Rio de Janeiro, RJ, Brasil., Roma EH; Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Imunologia e Imunogenética em Doenças Infecciosas, Rio de Janeiro, RJ, Brasil., Grinsztejn B; Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Pesquisa Clínica em DST e AIDS, Rio de Janeiro, RJ, Brasil., Lemos ADS; Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Centro Hospitalar, Rio de Janeiro, RJ, Brasil., Gorni N; Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Serviço de Nutrição, Rio de Janeiro, RJ, Brasil., Cruz AM; Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Serviço de Nutrição, Rio de Janeiro, RJ, Brasil., Almeida CF; Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Serviço de Nutrição, Rio de Janeiro, RJ, Brasil., Quintana MSB; Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Plataforma de Pesquisa Clínica, Rio de Janeiro, RJ, Brasil., Bonecini-Almeida MDG; Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Imunologia e Imunogenética em Doenças Infecciosas, Rio de Janeiro, RJ, Brasil., Brito PD; Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Serviço de Nutrição, Rio de Janeiro, RJ, Brasil.
Publikováno v:
Memorias do Instituto Oswaldo Cruz [Mem Inst Oswaldo Cruz] 2020 Jan 31; Vol. 114, pp. e190350. Date of Electronic Publication: 2020 Jan 31 (Print Publication: 2020).
Autor:
da Rocha NP; Laboratory of Immunology and Immunogenetics in Infectious Diseases, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Avvad-Portari E; Department of Pathologic Anatomy, Fernandes Figueira Woman, Child and Adolescent National Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Russomano F; Women's Health Care Area, Fernandes Figueira Woman, Child and Adolescent National Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Roma EH; Laboratory of Immunology and Immunogenetics in Infectious Diseases, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Pinto AC; Department of Biochemistry, State University of Rio de Janeiro, Rio de Janeiro, Brazil., Klumb E; Department of Rheumatology, State University of Rio de Janeiro, Rio de Janeiro, Brazil., Macedo J; Department of Biochemistry, State University of Rio de Janeiro, Rio de Janeiro, Brazil., Fernandes ATG; Laboratory of Immunology and Immunogenetics in Infectious Diseases, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., da Glória Bonecini-Almeida M; Laboratory of Immunology and Immunogenetics in Infectious Diseases, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Publikováno v:
Oncotarget [Oncotarget] 2019 Jan 29; Vol. 10 (9), pp. 953-965. Date of Electronic Publication: 2019 Jan 29 (Print Publication: 2019).
Autor:
Schor D; Laboratory of Immunology and Immunogenetics in Infectious Diseases, Evandro Chagas National Institute of Infectious Diseases, FIOCRUZ, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21040-360, Brazil.; Laboratory for Clinical Research in Neuroinfections, Evandro Chagas National Institute of Infectious Diseases, FIOCRUZ, Rio de Janeiro, RJ, Brazil., Porto LC; Histocompatibility and Cryopreservation Laboratory, Policlinica Piquet Carneiro, Rio de Janeiro State University (UERJ), Rio de Janeiro, RJ, Brazil., Roma EH; Laboratory of Immunology and Immunogenetics in Infectious Diseases, Evandro Chagas National Institute of Infectious Diseases, FIOCRUZ, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21040-360, Brazil. eric.roma@ini.fiocruz.br., Quintana MSB; Clinical Research Platform, Evandro Chagas National Institute of Infectious Diseases, FIOCRUZ, Rio de Janeiro, RJ, Brazil., Fabricio-Silva GM; Histocompatibility and Cryopreservation Laboratory, Policlinica Piquet Carneiro, Rio de Janeiro State University (UERJ), Rio de Janeiro, RJ, Brazil., Bonecini-Almeida MG; Laboratory of Immunology and Immunogenetics in Infectious Diseases, Evandro Chagas National Institute of Infectious Diseases, FIOCRUZ, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21040-360, Brazil., Araújo AQ; Laboratory for Clinical Research in Neuroinfections, Evandro Chagas National Institute of Infectious Diseases, FIOCRUZ, Rio de Janeiro, RJ, Brazil., Andrada-Serpa MJ; Laboratory for Clinical Research in Neuroinfections, Evandro Chagas National Institute of Infectious Diseases, FIOCRUZ, Rio de Janeiro, RJ, Brazil.
Publikováno v:
BMC infectious diseases [BMC Infect Dis] 2018 Nov 22; Vol. 18 (1), pp. 593. Date of Electronic Publication: 2018 Nov 22.
Autor:
Holanda MT; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. marcelo.holanda@ini.fiocruz.br., Mediano MFF; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Hasslocher-Moreno AM; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Xavier SS; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Saraiva RM; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Sousa AS; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Maciel ER; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Carneiro FM; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., da Silva PS; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Sangenis LHC; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Veloso HH; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Cardoso CSA; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Bonecini-Almeida MDG; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Souza AL; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Roma EH; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Azevedo MJ; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Pereira-Silva FS; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Pimentel LO; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Mendes MO; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Garzoni LR; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Gonzaga BMS; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Carvalho ACC; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Brasil PEAA; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Sperandio da Silva GM; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Araújo-Jorge TC; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Publikováno v:
Trials [Trials] 2018 Sep 19; Vol. 19 (1), pp. 507. Date of Electronic Publication: 2018 Sep 19.
Autor:
Carneiro MBH; Snyder Institute for Chronic Diseases, Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4Z6, Canada.; Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais 31270-901, Brazil., Roma EH; Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais 31270-901, Brazil.; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20852; and., Ranson AJ; Snyder Institute for Chronic Diseases, Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4Z6, Canada., Doria NA; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20852; and., Debrabant A; Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, MD 20993., Sacks DL; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20852; and., Vieira LQ; Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais 31270-901, Brazil., Peters NC; Snyder Institute for Chronic Diseases, Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4Z6, Canada; ncpeters@ucalgary.ca.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2018 Jan 01; Vol. 200 (1), pp. 196-208. Date of Electronic Publication: 2017 Nov 20.